Prophylaxis strategy prevents perinatal HBV transmission

Prophylaxis strategy prevents perinatal HBV transmission

(HealthDay)—Prenatal screening followed by immunoprophylaxis for infants of mothers with chronic hepatitis B virus (HBV) infection decreases perinatal transmission, according to research published online May 27 in the Annals of Internal Medicine.

Ai Kubo, Ph.D., of Kaiser Permanente in Oakland, Calif., and colleagues conducted an observational study of 4,446 infants born to 3,253 HBV-positive mothers. The authors sought to assess the efficacy of an immunoprophylaxis program.

The researchers found that the infant HBV per 100 births were 3.37 (95 percent confidence interval [CI], 2.08 to 5.14) for e antigen-positive mothers and 0.04 (95 percent CI, 0.001 to 0.24) for e antigen-negative mothers. Among mothers who received testing, the lowest viral load level associated with transmission of HBV was 6.32 × 107 IU/mL. Infection rates per 100 births were 3.61 (95 percent CI, 0.75 to 10.56) among mothers with of 5 × 107 IU/mL or greater (83 births) and 0 among with viral loads less than 5 × 107 IU/mL (831 births), regardless of e antigen status.

"A negative e antigen status or a viral load less than 5 × 107 IU/mL (90.9 percent of women tested) identifies women at extremely low risk for transmission after immunoprophylaxis who are unlikely to benefit from further interventions," the authors write.

More information: Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Chinese-built Ebola center dedicated in Liberia

2 hours ago

China, one of the first countries to send aid to battle Ebola in West Africa, ramped up the assistance significantly Tuesday by opening a 100-bed treatment center in Liberia as rows of uniformed Chinese army ...

Superbug in SE Michigan shows recent decline

5 hours ago

A new study finds a decrease in an emergent strain of methicillin-resistant S. aureus (MRSA) that is resistant to last line defense antibiotics. Researchers examined the prevalence of vancomycin-resistant Staphylococcus aureus (V ...

First Italian with Ebola takes trial drug

5 hours ago

An Italian doctor battling the deadly Ebola virus on Tuesday began treatment with an experimental drug in Italy's leading hospital for infectious diseases.

User comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.